文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

心肺复苏期间治疗性低温对神经功能结局的影响:系统评价与Meta分析

Impact of therapeutic hypothermia during cardiopulmonary resuscitation on neurologic outcome: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2021-02-02
一句话结论与院内标准目标温度管理相比,心肺复苏期间启动治疗性低温未改善院外心脏骤停患者的神经功能结局、ROSC率或生存出院率。

该研究为系统评价与Meta分析,最终纳入8项研究(共3493例患者,含4项RCT),比较院外心脏骤停患者心肺复苏期间启动治疗性低温(IATH)与院内标准目标温度管理(TTM)的效果。主要终点良好神经功能结局(FO)无显著差异(OR 0.96, 95%CI 0.68-1.37; p=0.84);ROSC率(OR 1.11, 95%CI 0.83-1.49; p=0.46)与生存出院率(OR 0.91, 95%CI 0.73-1.14; p=0.43)亦无显著差异。ROSC分析存在显著异质性(I2=69%)。结论基于极低确定性证据,不支持常规在复苏期间启动治疗性低温。

要点

  • 与院内标准TTM相比,IATH未改善OHCA患者良好神经功能结局(OR 0.96, 95%CI 0.68-1.37; p=0.84)。
  • IATH未提高ROSC率(OR 1.11, 95%CI 0.83-1.49; p=0.46),该分析异质性显著(I2=69%)。
  • IATH未改善生存出院率(OR 0.91, 95%CI 0.73-1.14; p=0.43)。
  • 两项RCT探索经鼻蒸发冷却和冷液体,即使仅分析初始可除颤心律患者,FO仍无差异(OR 1.62, 95%CI 1.00-2.64; p=0.05)。
  • 结论基于极低确定性证据,不支持常规在CPR期间启动治疗性低温以改善神经结局。

适用人群与场景

  • 院外心脏骤停(OHCA)患者,比较心肺复苏期间启动治疗性低温(IATH)与院内标准目标温度管理(TTM)的研究对象;纳入标准为比较IATH与标准院内TTM的研究。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,最终纳入8项研究(n=3493例患者,包括4项RCT)。
  • 主要终点:良好神经功能结局(FO),IATH组与对照组无显著差异(OR 0.96, 95%CI 0.68-1.37; p=0.84)。
  • 次要终点:ROSC率无显著差异(OR 1.11, 95%CI 0.83-1.49; p=0.46),异质性I2=69%;生存出院率无显著差异(OR 0.91, 95%CI 0.73-1.14; p=0.43)。
  • 两项RCT探索经鼻蒸发冷却,两项RCT探索冷液体,FO均无差异;仅分析初始可除颤心律患者时FO仍无差异(OR 1.62, 95%CI 1.00-2.64; p=0.05)。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入4项RCT和4项观察性研究(原文未明确各设计数量,仅提及包括4项RCT)。
  • 证据等级:原文结论基于极低确定性证据(very low certainty of evidence)。
  • 局限:ROSC分析存在显著异质性(I2=69%);原文未提及其他局限。

对床旁实践的改变

  • 基于极低确定性证据,不推荐常规在CPR期间启动治疗性低温以改善OHCA患者神经功能结局、ROSC率或生存出院率;适用人群为OHCA患者,不适用人群原文未提及。
  • 临床决策时应考虑证据确定性极低,且不同冷却方法(经鼻蒸发冷却、冷液体)均未显示获益;常见陷阱为将研究方案中的冷却方法误作常规推荐。

指南或共识出处

  • 原文未提及指南或共识名称;系统评价注册号PROSPERO CRD42019130322。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Therapeutic cooling initiated during cardiopulmonary resuscitation (intra arrest therapeutic hypothermia, IATH) provided diverging effect on neurological outcome of out-of-hospital cardiac arrest (OHCA) patients depending on the initial cardiac rhythm and the cooling methods used.

METHODS: We performed a systematic search of PubMed, EMBASE and the CENTRAL databases using established Medical Subject Headings (MeSH) terms for IATH and OHCA. Only studies comparing IATH to standard in-hospital targeted temperature management (TTM) were selected. We used the revised Cochrane RoB-2 and the Newcastle-Ottawa scale tool to assess risk of bias of each study. Primary outcome was favorable neurological outcome (FO); secondary outcomes included return of spontaneous circulation (ROSC) rate and survival to hospital discharge.

RESULTS: Out of 20,950 studies, 8 studies (n = 3493 patients, including 4 randomized trials, RCTs) were included in the final analysis. Compared to controls, the use of IATH was not associated with improved FO (OR 0.96 [95% CIs 0.68-1.37]; p = 0.84), increased ROSC rate (OR 1.11 [95% CIs 0.83-1.49]; p = 0.46) or survival (OR 0.91 [95% CIs 0.73-1.14]; p = 0.43). Significant heterogeneity among studies was observed for the analysis of ROSC rate (I2 = 69%). Trans-nasal evaporative cooling and cold fluids were explored in two RCTs each and no differences were observed on FO, event when only patients with an initial shockable rhythm were analyzed (OR 1.62 [95% CI 1.00-2.64]; p = 0.05].

CONCLUSIONS: In this meta-analysis, IATH was not associated with improved neurological outcome when compared to standard in-hospital TTM, based on very low certainty of evidence.

CLINICAL TRIAL REGISTRATION: PROSPERO (CRD42019130322).

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Annoni F, Peluso L, Fiore M, et al. Impact of therapeutic hypothermia during cardiopulmonary resuscitation on neurologic outcome: A systematic review and meta-analysis. Resuscitation. 2021. PMID: 33545107. doi:10.1016/j.resuscitation.2021.01.029

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。